Expertise in
2
conditions

Angel Artal

Zaragoza, AR, ES 
Clinical Trials:Currently Recruiting for 1 Trial
Expertise in
2
conditions
Zaragoza, AR, ES 

Overview

Angel Artal practices practicing medicine in Zaragoza, Spain.

Artal is highly rated in 2 conditions, according to our data. Their clinical expertise encompasses Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), EGFR Positive Lung Cancer, and Small Cell Lung Cancer (SCLC).

They are actively involved in clinical research, co-authoring 23 peer reviewed articles and participating in 6 clinical trials.

Locations

Zaragoza, AR, Spain
Other Locations
Barcelona, CT, Spain

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

6 Clinical Trials

Thoracic Tumours Register
Thoracic Tumours Register
Enrollment Status: Recruiting
Publish Date: April 23, 2026
A Randomised, Open-label Phase III Trial Evaluating the Addition of Denosumab to Standard First-line Anticancer Treatment in Advanced NSCLC
A Randomised, Open-label Phase III Trial Evaluating the Addition of Denosumab to Standard First-line Anticancer Treatment in Advanced NSCLC
Enrollment Status: Terminated
Publish Date: September 08, 2026
Intervention Type: Other, Drug
Study Phase: Phase 3
A Phase II Open-label Multicenter Exploratory Study to Assess Efficacy of Pembrolizumab Re-challenge as Second or Further Line in Patients With Advanced Non - Small Cell Lung Cancer
A Phase II Open-label Multicenter Exploratory Study to Assess Efficacy of Pembrolizumab Re-challenge as Second or Further Line in Patients With Advanced Non - Small Cell Lung Cancer
Enrollment Status: Completed
Publish Date: March 24, 2025
Intervention Type: Drug
Study Drug: Pembrolizumab
Study Phase: Phase 2
Observational Study on the Effectiveness and Safety of Vaccination Anti-SARS-CoV2 in Patients With Lung Cancer
Observational Study on the Effectiveness and Safety of Vaccination Anti-SARS-CoV2 in Patients With Lung Cancer
Enrollment Status: Completed
Publish Date: July 29, 2022
Intervention Type: Drug
Observational Retrospective Register of Spanish Lung and Melanoma Cancer Patients With COVID19 Disease
Observational Retrospective Register of Spanish Lung and Melanoma Cancer Patients With COVID19 Disease
Enrollment Status: Completed
Publish Date: June 27, 2022
Spanish Real World Data on Unresectable Stage III NSCLC Patients Treated With Durvalumab After Chemoradiotherapy.
Spanish Real World Data on Unresectable Stage III NSCLC Patients Treated With Durvalumab After Chemoradiotherapy.
Enrollment Status: Completed
Publish Date: June 07, 2022
Intervention Type: Drug
View 5 Less Clinical Trials

23 Total Publications

Brief report: High incidence of peridiagnosis thromboembolic events in patients with BRAF-mutant lung cancer.
Brief report: High incidence of peridiagnosis thromboembolic events in patients with BRAF-mutant lung cancer.
Journal: Thrombosis research
Published: June 12, 2023

Frequently Asked Questions about Angel Artal

Is Angel Artal a top-rated expert for Lung Cancer?

MediFind is an objective health platform that identifies experts based on real-world data. Angel Artal is classified as an Advanced expert for Lung Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Angel Artal participate in research or clinical trials?

Yes. Angel Artal has published 23 articles and abstracts on conditions like Lung Cancer. You can view a list of Angel Artal's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Artal's expertise for a condition
ConditionClose
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile